The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity
Open accessAbstract
In breast cancer, genetic heterogeneity, the lack of actionable targets and immune evasion all contribute to the limited clinical response rates to immune checkpoint blockade therapy. Here, we report a high-throughput screen based on the functional interaction of mouse- or patient-derived breast tumour organoids and tumour-specific cytotoxic T cells for the identification of epigenetic inhibitors that promote antigen presentation and potentiate T-cell-mediated cytotoxicity. We show that the epigenetic inhibitors GSK-LSD1, CUDC-101 and BML-210, identified by the screen, display antitumour activities in orthotopic mammary tumours in mice, that they upregulate antigen presentation mediated by the major histocompatibility complex class I on breast tumour cells and that treatment with BML-210 substantially sensitized breast tumours to the inhibitor of the checkpoint programmed death-1. Standardized measurements of tumour-cell killing activity facilitated by tumour-organoid-T-cell screens may help with the identification of candidate immunotherapeutics for a range of cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A high-throughput screening, based on the interaction between patient-derived breast cancer organoids and tumor-specific cytotoxic T cells, identified three epigenetic inhibitors - BML-210, GSK-LSD1, and CUDC-101—that displayed significant antitumor effects.44”
From Drug repurposing for cancer therapy (2024) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Li, Y., Liu, Y., Xu, H., Jiang, G., der Jeught, K. V., Fang, Y., Zhou, Z., Zhang, L., Frieden, M., Wang, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06811-z · Cited by 47
Self-citationRetractedSubramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Gu, Z., Eils, R., & Schlesner, M. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw313 · Cited by 10,178
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204
McCarthy, D. J., Chen, Y., & Smyth, G. K. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks042 · Cited by 5,195
Cited by
Sorted by citations
Drug repurposing for cancer therapy
Xia, Y., Sun, M., Huang, H., & Jin, W.-L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01808-1 · Cited by 443
“44 In addition, the drug atorvastatin was found to inhibit angiogenesis in a dose-dependent manner through the downregulation of vascular endothelial growth factor (VEGF), CD31, and Bcl-2 in a co-culture of glioblastoma organoids and human umbilical vein endothelial cells in fi brin gels, indicating…”
BackgroundTumor organoids: applications in cancer modeling and potentials in precision medicine
Xu, H., Jiao, D., Liu, A., & Wu, K. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01278-4 · Cited by 286
OrganoID: A versatile deep learning platform for tracking and analysis of single-organoid dynamics
Matthews, J. M., Schuster, B., Kashaf, S. S., Liu, P., Ben-Yishay, R., Ishay-Ronen, D., Izumchenko, E., Shen, L., Weber, C. R., Bielski, M. C., et al. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010584 · Cited by 179
3D cell cultures toward quantitative high-throughput drug screening
Wang, Y., & Jeon, H. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.03.014 · Cited by 143
Strategies for 3D bioprinting of spheroids: A comprehensive review
Banerjee, D., Singh, Y. P., Datta, P., Özbolat, V., O'Donnell, A., Yeo, M., & Ozbolat, I. T. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121881 · Cited by 121
Metadata
- Authors
- Zhou, Z., Van der Jeught, K., Fang, Y., Yu, T., Li, Y., Ao, Z., Liu, S., Zhang, L., Yang, Y., Eyvani, H., Cox, M. L., Wang, X., He, X., Ji, G., Schneider, B. P., Guo, F., Wan, J., Zhang, X., & Lu, X.
- Affiliations
- Indiana University Indianapolis (US)
- Indiana University Bloomington (US)
- Shanghai University of Traditional Chinese Medicine (CN)
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center (US)
- University of Maryland, College Park (US)
- Corresponding author
- Zhang, Lu
- Zhang, Xinna
- Lu, Xiongbin
- ORCID
- Venue
- Nature Biomedical Engineering
- Published
- 2021-11-01
- Volume
- 5
- Issue
- 11
- Pages
- 1320-1335
- ISSN
- 2157-846X (ISSN-L)
- PMC
- PMC8647932
- OpenAlex
- W3210520893
- Cited by
- 107
- References
- 75
- Citations by year
- 2026: 14 · 2025: 20 · 2024: 28 · 2023: 26 · 2022: 16 · 2021: 3
- FWCI
- 6.65
- Type
- journal article
- Language
- en
- Update notices
- correction (2023-08-30)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA206366, CA243023, CA203737, CA222251)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- breast cancer, tumor organoids, epigenetic inhibitors, antigen presentation, MHC class I, T cell cytotoxicity, immune checkpoint blockade, PD-1, CUDC-101, high-throughput screening, immunotherapy, tumor immune evasion
- MeSH terms
- Animals, Breast Neoplasms, Female, Humans, Organoids, Antigen Presentation, CD8-Positive T-Lymphocytes, Epigenesis, Genetic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
